Mr Tanner has considerable experience at both senior executive and board level, bringing more than 25 years' experience in healthcare and strategy. Shane has orchestrated and been responsible for numerous small and large-scale acquisitions. He has also helped to establish and guide number of significant businesses. Shane is also currently Chairman of two ASX listed healthcare businesses, Zenitas Healthcare Limited and Rhythm Biosciences Limited. Shane is also Chairman of ASX listed Funtastic Limited. Previously, Shane was CEO of Symbion Health, one of Australia's largest diagnostic businesses and Chairman of Vision Eye Institute. He is Member of Investment Review Committee.

Mr Nicholl is currently the CEO of one of Paragon's businesses, a company in the orthopaedics market in Australia and New Zealand. Mr Nicholl has experience in the medical devices industry having occupied senior executive roles for the companies including Stryker and Cochlear.

Mr Simari is also a Non-Executive Director of listed ASX MedTech company Novita Healthcare (ASX: NHL).

Mr Sam has held ASX listed board positions including Chairman of Money 3, Director of Hutchison's Childcare Services and Managing Director of Nova Health. Prior to his appointments to ASX listed companies, Geoffrey undertook numerous Chief Executive positions at Adelaide based hospitals. He is currently the Co-Founder and Director of HealtheCare Australia Pty Ltd. He is Chairman of Investment Review Committee, Member of Risk Committee.

Mr Stewart is an experienced company executive and director having occupied numerous senior executive and board roles over the past 25 years. He established and grew a company in Australia and New Zealand (Market Equity Pty Ltd) before selling to a large multinational group (Aegis PLC). Brent has a long association with various segments of the healthcare sector in Australia and Internationally. Currently, Brent occupies Non-Executive roles at HBF Health Ltd, Etherington Inc and Argonaut Ltd. He is Member of Risk Committee.

Mr Li has over twenty-nine years of experience in the pharmaceutical services industry and experience in international trading and management. Mr Paul Li is the Founder and Chairman of China Pioneer Pharma Holdings Limited, a company listed on the main board of the Stock Exchange of Hong Kong Limited (stock code HK.01345), and he is the shareholder of PGC through Perpetual Corporate Trust Ltd. With effect from 10 April 2015, Mr Li was appointed as a director of Novabay Pharmaceuticals Inc., a company listed on the NYSE(NBY). Mr Li is also the director of Pioneer Pharma (BVI) Co., Ltd. and Tian Tian Limited.

-

-